About UCSF Search UCSF UCSF Medical Center

Albert J. Chang, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
chang_albert

Assistant Professor in Residence, Dept of Radiation Oncology, UCSF

Phone: (415) 353-7175 (appts)

View on UCSF Profiles


Additional Websites


Education

1997, UC DavisBS (SCL)Biochemistry
2007, Boston University School of Medicine, Boston, MAMD/PhD
2008, Kaiser Permanente Oakland, Oakland, CAInternship
2012, Washington University School of Medicine, Saint-Louis, MOResidentRadiation Therapy


Professional Experience

  • 2012-present
    Assistant Professor in Residence, Radiation Oncology, UCSF

Honors & Awards

  • 1997
    Phi Beta Kappa Honor Society

  • 1998
    Tsai Foundation Medical Student Scholarship

  • 2004
    Henry I. Russek Student Research Achiement

  • 2005
    Karin Grunenbaum Cancer Research Foundation Grant

  • 2008-2012
    American Board of Radiology, Leonard B. Holman Research Pathway Resident Award

  • 2010
    American Radium Society Travel Grant Award

  • 2010
    National Cancer Care Network (NCCN) Fellow

  • 2011
    ASTRO Cancer Imaging and Radiation Therapy Symposium Travel Grant

  • 2011
    Society of Nuclear Medicine Annual Meeting Travel

  • 2011
    Seattle Prostate Institute Brachytherapy Course

  • 2011
    American Association for Cancer Research Molecular Biology in Clinical Oncology Workshop

  • 2011
    Radiation Therapy Oncology Group/American College of Radiology Fellowship

  • 2011
    RSNA Research Resident Fellow Grant

Selected Publications

  1. Chang AJ, Autio KA, Roach M, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014 Jun; 11(6):308-23.
    View on PubMed
  2. Anwar M, Weinberg V, Chang AJ, Hsu IC, Roach M, Gottschalk A. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014; 9(1):42.
    View on PubMed
  3. Beaino W, Guo Y, Chang AJ, Anderson CJ. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. J Biol Inorg Chem. 2014 Mar; 19(3):427-38.
    View on PubMed
  4. Chang AJ, Sohn R, Lu ZH, Arbeit JM, Lapi SE. Detection of rapalog-mediated therapeutic response in renal cancer xenografts using 64Cu-bevacizumab immunoPET. PLoS One. 2013; 8(3):e58949.
    View on PubMed
  5. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang AJ, Hsu IC. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):324-9.
    View on PubMed
  6. Chang AJ, Roach M. Cautious optimism for extreme dose escalation in prostate cancer. Eur Urol. 2013 Dec; 64(6):939-40.
    View on PubMed
  7. Chang AJ, De Silva RA, Lapi SE. Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor. Mol Imaging. 2013 Jan-Feb; 12(1):17-27.
    View on PubMed
  8. Gay HA, Jin JY, Chang AJ, Ten Haken RK. Utility of normal tissue-to-tumor a/ß ratio when evaluating isodoses of isoeffective radiation therapy treatment plans. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):e81-7.
    View on PubMed
  9. Chang AJ, Roach M. Radium-223: down to the bone, and less is more. Oncology (Williston Park). 2012 Apr; 26(4):342, 344.
    View on PubMed
  10. Chang AJ, Desilva R, Jain S, Lears K, Rogers B, Lapi S. 89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors. Pharmaceuticals (Basel). 2012; 5(1):79-93.
    View on PubMed
  11. Chang AJ, Zhao H, Wahab SH, Moore K, Taylor M, Zoberi I, Powell SN, Klein EE. Video surface image guidance for external beam partial breast irradiation. Pract Radiat Oncol. 2012 Apr-Jun; 2(2):97-105.
    View on PubMed
  12. Chang AJ, Dehdashti F, Bradley JD. The role of positron emission tomography for non-small cell lung cancer. Pract Radiat Oncol. 2011 Oct-Dec; 1(4):282-8.
    View on PubMed
  13. Chang AJ, Richardson S, Grigsby PW, Schwarz JK. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1; 82(1):263-9.
    View on PubMed
  14. Chang AJ, Bradley JD. Clinical perspectives on dose escalation for non-small-cell lung cancer. Clin Lung Cancer. 2010 Sep 1; 11(5):299-302.
    View on PubMed
  15. Chang AJ, Song DH, Wolfe MM. Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. J Biol Chem. 2006 May 26; 281(21):14700-10.
    View on PubMed
  16. Yao M, Zhou W, Sangha S, Albert A, Chang AJ, Liu TC, Wolfe MM. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1618-28.
    View on PubMed
  17. Moore TC, Jepeal LI, Boylan MO, Singh SK, Boyd N, Beer DG, Chang AJ, Wolfe MM. Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells. Regul Pept. 2004 Aug 15; 120(1-3):195-203.
    View on PubMed
  18. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003 Oct; 9(10):1053-61.
    View on PubMed

Go to UCSF Profiles, powered by CTSI